|Print This Page E-mail this to a Friend|
Oncology Program at Texas Health Presbyterian Hospital Dallas Receives Commendations From Commission on Cancer|
DALLAS — The American College of Surgeons’ Commission on Cancer has given the cancer program at Texas Health Presbyterian Hospital Dallas commendation in all nine categories.
“This recognizes the hard work of all the people in our program, from administrators to nurses to physicians,” said Dr. Pat Fulgham, surgical director of oncology at Texas Health Dallas. “Receiving this designation validates Texas Health Dallas’ commitment to clinical excellence and compassionate, patient-centered care.”
The recognition makes Texas Health Dallas’ program eligible to receive the Outstanding Achievement Award by the Commission on Cancer, one of the highest honors for cancer programs in the United States.
Texas Health Dallas received commendation in each of the nine categories by exceeding specified criteria set by the Commission on Cancer. The hospital was recognized for treating a high number of cancer patients each year, providing a full range of diagnostic and treatment services, and participating in clinical research. The hospital also provides a cancer registry that follows patients from diagnosis through treatment and offers lifelong follow-up.
“Only one in four hospitals that treat cancer patients are accredited cancer programs, and even fewer are recognized in all categories,” said Matt Schneider, administrative director of oncology at Texas Health Dallas. “We’re proud to be among that select group.”
Just to be accredited by the Commission on Cancer, programs must meet a complex set of requirements for oncology services.
The application process, which included a site visit, requires that hospitals submit three years of data to demonstrate that the program meets the commission’s rigorous standards for providing comprehensive care for cancer patients, including state-of-the-art equipment and services, and maintaining a multidisciplinary approach to patient care.
The patient data collected by certified tumor registrars at Texas Health Dallas is provided to researchers and organizations such as the American Cancer Society, National Cancer Institute and Centers for Disease Control to evaluate quality of care, outcomes, and screening and prevention programs.
About Texas Health Presbyterian Hospital Dallas